Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by "Биовет" Ад, Жгумова Тодорка, Караниколова МарианаfiledCritical"Биовет" Ад
Priority to BG100647ApriorityCriticalpatent/BG100647A/en
Publication of BG100647ApublicationCriticalpatent/BG100647A/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Medicinal Preparation
(AREA)
Abstract
Лекарствената форма намира приложение във ветеринарната медицина за лечение на ендои ектопаразити. Инжекционен разтвор на авермектин и ивермектин се получава чрез разтварянето им в диметилсулфоксид вколичество от 10 до 30% и добавяне на вода и пропиленгликол. Инжекционен разтвор на ивермектин се получава също чрез разтварянето му в етилов алкохол в количество от 8 до 10% и добавяне на смес от пропиленгликол и вода.The pharmaceutical form is used in veterinary medicine to treat endoid ectoparasites. A solution for injection of avermectin and ivermectin is prepared by dissolving them in dimethylsulfoxide at a rate of 10 to 30% and adding water and propylene glycol. Ivermectin injectable solution is also prepared by dissolving it in ethyl alcohol in an amount of 8 to 10% and adding a mixture of propylene glycol and water.
BG100647A1996-06-061996-06-06Perenteral medicamentous form based on avremectine and ivermectine
BG100647A
(en)